Berman Capital Advisors’s Bausch Health BHC Stock Holding History

Berman Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35	Closed	–	–	1597
2020 Q2	$0	Sell	35 -16	-31%	-$282	﹤0.01%	1611
2020 Q1	$0	Buy	+51	New	+$1.23K	﹤0.01%	1469

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Berman Capital Advisors's BHC Position: Q3 2020 in Review

Berman Capital Advisors sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 35 shares.

Berman Capital Advisors first reported a position in BHC in Q1 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2020. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Berman Capital Advisors reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Berman Capital Advisors sold 35 Bausch Health shares in Q3 2020.
Berman Capital Advisors first reported a position in Bausch Health in Q1 2020 and held it in 2 quarters.
Berman Capital Advisors's Bausch Health position peaked at $0 in Q2 2020.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Berman Capital Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.